Telenzepine
- Level
- Commodity
- Parent
- 51151500
- Below
- 0
- Links · KBLI
- 8
Definition
UNSPSC 51151530This classification denotes an antimuscarinic agent with the molecular formula C19H22N4O2S, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier 0990EG3K10, chemically known as 4,9-dihydro-3-methyl-4-((4-methyl-1-piperazinyl)acetyl)-10h-thieno(3,4-b)(1,5)benzodiazepin-10-one but generally known as telenzepine, which bears US NIH Compound Identifier 5387. European Medicines Agency schedules Telenzepine in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB10871MIG. The term TELENZEPINE is an International Non-Proprietary Name. TELENZEPINE is scheduled in the U.S. International Trade Commission's Harmonized Tariff System (HTS) Pharmaceutical Appendix. Most nations schedule telenzepine under HS 29349990 and SITC 51579. As of Q4 2014, TELENZEPINE remains the US FDA Preferred Term for this commodity. Telenzepine bears US NLM identifiers UMLS ID C0076066 and NCI Concept Code C75285. SMILES: S1C(C2N(C(=O)CN3CCN(CC3)C)C3C([NH]C(=O)C2C1)CCCC3)C.
Same parent
Under 51151500 · 44Activities that produce or sell this
KBLI · 8Inherited from family 51150000.
Warning
The links were generated with a large language model (Gemini 3.5 Flash), matching UNSPSC at the family level to KBLI at the kelompok level. Some of them maybe are wrong, so check any link you intend to rely on.